Besins Healthcare entered the Men’s Health area in Europe in 1982 when it developed the first dihydrotestosterone gel for the treatment of hypogonadism and gynaecomastia (breast enlargement).

We built on that success and our hormone therapy expertise to develop the world’s first transdermal testosterone gel therapy to treat hypogonadism. Androgel® (Testogel®) is the world’s leading brand of testosterone replacement therapy for treating testosterone deficiency. This has made us the #1 global leader in testosterone replacement therapy[1]IQVIA Global Sales report Q4-2019.

Product support

BRAND NAME: Testogel®

DESCRIPTION: Testosterone



Patient Support

Access patient and product resources for Testosterone Deficiency Syndrome.


About Hypogonadism

(Testosterone Deficiency)

Male hypogonadism is a clinical syndrome caused by testosterone deficiency which may adversely affect multiple organ functions and quality of life [2] Nieschlag E, Behre HM (eds). Andrology: male reproductive health and dysfunction. 3rd edn. Heidelberg: Springer, 2010..

Testosterone deficiency can be of primary or of secondary origin, and it usually increases with age, although this can also be related to certain co-morbidities which are prevalent in older men. An annual decline in circulating testosterone of 0.4-2.0% has been reported [3-4] Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008 Jul;93(7):2737-45.and in middle-aged men the incidence was found to be 6% [5] Hall SA, Esche GR, Araujo AB, et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab 2008 Oct;93(10):3870-7.. It is more prevalent in older men and in men taking some medications. Generally speaking, a low testosterone level is often indicative of a poor health status.

Decreases in testosterone levels may increase the risk of osteoporosis, sexual dysfunction, fatigue, cardiovascular disease, and mood disturbances [6] AACE Guideline for Clinical Practice for the Evaluation and Treatment of Hypogonadism in Adult Male Patients- 2002 Update. ENDOCRINE PRACTICE Vol 8 No. 6 November/December 2002.

Hypogonadism is associated with acute and chronic illness. Some of the systemic illnesses associated with hypogonadism include burn injury, stroke, cancer, HIV disease, myocardial infarction, diabetes, obesity, surgical stress, visceral obesity, diminished cognitive function, metabolic syndrome, changes in mood, insulin resistance and type 2 diabetes (BSSM 2017) [7] Kalyani, R., Male Hypogonadism in Systemic Disease. Endocrinol Metab Clin N Am. 36 (2007) 333–348..